RXRX
Price
$6.87
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
TRDA
Price
$17.37
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
7 days until earnings call
Ad is loading...

RXRX vs TRDA

Header iconRXRX vs TRDA Comparison
Open Charts RXRX vs TRDABanner chart's image
Recursion Pharmaceuticals
Price$6.87
Change-$0.00 (-0.00%)
Volume$4.55M
CapitalizationN/A
Entrada Therapeutics
Price$17.37
Change-$0.00 (-0.00%)
Volume$66.14K
CapitalizationN/A
View a ticker or compare two or three
RXRX vs TRDA Comparison Chart
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
RXRX vs. TRDA commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Buy and TRDA is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (RXRX: $6.87 vs. TRDA: $17.37)
Brand notoriety: RXRX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 94% vs. TRDA: 49%
Market capitalization -- RXRX: $1.97B vs. TRDA: $594.45M
RXRX [@Biotechnology] is valued at $1.97B. TRDA’s [@Biotechnology] market capitalization is $594.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 1 green, 4 red.
According to our system of comparison, TRDA is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • RXRX’s TA Score: 5 bullish, 3 bearish.
  • TRDA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than TRDA.

Price Growth

RXRX (@Biotechnology) experienced а +1.63% price change this week, while TRDA (@Biotechnology) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

RXRX is expected to report earnings on Mar 04, 2025.

TRDA is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.97B) has a higher market cap than TRDA($594M). TRDA YTD gains are higher at: 15.109 vs. RXRX (-30.325). TRDA has higher annual earnings (EBITDA): 96.9M vs. RXRX (-348.35M). RXRX (474M) and TRDA (470M) have equal amount of cash in the bank . TRDA has less debt than RXRX: TRDA (64.4M) vs RXRX (89.9M). TRDA has higher revenues than RXRX: TRDA (239M) vs RXRX (48.6M).
RXRXTRDARXRX / TRDA
Capitalization1.97B594M332%
EBITDA-348.35M96.9M-359%
Gain YTD-30.32515.109-201%
P/E RatioN/A5.29-
Revenue48.6M239M20%
Total Cash474M470M101%
Total Debt89.9M64.4M140%
TECHNICAL ANALYSIS
Technical Analysis
RXRXTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+6.02%
BEAM - RXRX
62%
Loosely correlated
+3.71%
CRSP - RXRX
57%
Loosely correlated
+4.96%
PRME - RXRX
55%
Loosely correlated
+4.47%
NTLA - RXRX
54%
Loosely correlated
+2.45%
EXAI - RXRX
54%
Loosely correlated
+6.30%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with AVIR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+2.24%
AVIR - TRDA
39%
Loosely correlated
+2.39%
PLRX - TRDA
39%
Loosely correlated
+5.02%
INZY - TRDA
37%
Loosely correlated
-0.21%
RXRX - TRDA
36%
Loosely correlated
+6.02%
PTGX - TRDA
35%
Loosely correlated
+1.99%
More